Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases

Annals of Diagnostic Pathology - Tập 14 - Trang 8-14 - 2010
Julie C. Fanburg-Smith1, Aaron Auerbach2,3, Jayson S. Marwaha1, Zengfeng Wang3, Mariarita Santi4, Alexander R. Judkins4, Elisabeth J. Rushing5
1Department of Orthopaedic and Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington DC 20306-6000, USA
2Department of Hematopathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
3Department of Immunohistochemistry, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
4Department of Pathology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA
5Department of Neuropathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA

Tài liệu tham khảo

Nakashima, 1986, Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases, Cancer, 57, 2444, 10.1002/1097-0142(19860615)57:12<2444::AID-CNCR2820571233>3.0.CO;2-K Dantonello, 2008, Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups, Cancer, 112, 2424, 10.1002/cncr.23457 De, 2008, Congenital intracranial mesenchymal chondrosarcoma: case report and review of the literature in pediatric patients, Pediatr Dev Pathol, 11, 309, 10.2350/07-05-0279.1 Guccion, 1973, Extraskeletal mesenchymal chondrosarcoma, Arch Pathol, 95, 336 Salvador, 1971, Mesenchymal chondrosarcoma—observations on 30 new cases, Cancer, 28, 605, 10.1002/1097-0142(197109)28:3<605::AID-CNCR2820280312>3.0.CO;2-R Lightenstein, 1959, Unusual benign and malignant chondroid tumors of bone. A survey of some mesenchymal cartilage tumors and malignant chondroblastic tumors, including a few multicentric ones, as well as many atypical benign chondroblastomas and chondromyxoid fibromas, Cancer, 12, 1142, 10.1002/1097-0142(195911/12)12:6<1142::AID-CNCR2820120610>3.0.CO;2-D Lockhart, 1998, Mesenchymal chondrosarcoma of the jaws. Report of four cases, Int J Oral Maxillofac Surg, 27, 358, 10.1016/S0901-5027(98)80065-9 Vencio, 1998, Mesenchymal chondrosarcoma of the jaw bones: clinicopathologic study of 19 cases, Cancer, 82, 2350, 10.1002/(SICI)1097-0142(19980615)82:12<2350::AID-CNCR8>3.0.CO;2-W Rushing, 1996, Mesenchymal chondrosarcoma: a clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system, Cancer, 77, 1884, 10.1002/(SICI)1097-0142(19960501)77:9<1884::AID-CNCR19>3.0.CO;2-W Salvati, 2005, Central nervous system mesenchymal chondrosarcoma, J Exp Clin Cancer Res, 24, 317 Fletcher, 1988, Cartilaginous tumours of soft tissue, Appl Pathol, 6, 208 Scheithauer, 1978, Meningeal mesenchymal chondrosarcoma: report of 8 cases with review of the literature, Cancer, 42, 2744, 10.1002/1097-0142(197812)42:6<2744::AID-CNCR2820420633>3.0.CO;2-L Hsu, 1981, Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures, J Histochem Cytochem, 29, 577, 10.1177/29.4.6166661 Kulyk, 2000, Sox9 expression during chondrogenesis in micromass cultures of embryonic limb mesenchyme, Exp Cell Res, 255, 327, 10.1006/excr.1999.4784 Hoang, 2000, Mesenchymal chondrosarcoma: a small cell neoplasm with polyphenotypic differentiation, Int J Surg Pathol, 8, 291, 10.1177/106689690000800408 Wehrli, 2003, Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors, Hum Pathol, 34, 263, 10.1053/hupa.2003.41 Soderstrom, 2002, Molecular profiling of human chondrosarcomas for matrix production and cancer markers, Int J Cancer, 100, 144, 10.1002/ijc.10457 Sainati, 1993, A mesenchymal chondrosarcoma of a child with the reciprocal translocation (11;22)(q24;q12), Cancer Genet Cytogenet, 71, 144, 10.1016/0165-4608(93)90020-M Judkins, 2007, Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology, Adv Anat Pathol, 14, 335, 10.1097/PAP.0b013e3180ca8b08 Versteege, 1998, Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer, Nature, 394, 203, 10.1038/28212 Biegel, 2006, Molecular genetics of atypical teratoid/rhabdoid tumor, Neurosurg Focus, 20, E11, 10.3171/foc.2006.20.1.12 Roberts, 2004, The SWI/SNF complex—chromatin and cancer, Nat Rev Cancer, 4, 133, 10.1038/nrc1273 Judkins, 2004, Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms, Am J Surg Pathol, 28, 644, 10.1097/00000478-200405000-00013 Raoux, 2009, Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion, Am J Surg Pathol, 33, 954, 10.1097/PAS.0b013e31819b92d5 Hornick, 2009, Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma, Am J Surg Pathol, 33, 542, 10.1097/PAS.0b013e3181882c54